Lachert, E.; Lasocka, J.; Bielawski, A.; Sulkowska, E.; Guz, K.; Pyrc, K.; Dabrowska, A.; Wawryniuk-Malmon, A.; Letowska, M.; Tomasiewicz, K.;
et al. Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product. Viruses 2022, 14, 1328.
https://doi.org/10.3390/v14061328
AMA Style
Lachert E, Lasocka J, Bielawski A, Sulkowska E, Guz K, Pyrc K, Dabrowska A, Wawryniuk-Malmon A, Letowska M, Tomasiewicz K,
et al. Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product. Viruses. 2022; 14(6):1328.
https://doi.org/10.3390/v14061328
Chicago/Turabian Style
Lachert, Elzbieta, Joanna Lasocka, Artur Bielawski, Ewa Sulkowska, Katarzyna Guz, Krzysztof Pyrc, Agnieszka Dabrowska, Agata Wawryniuk-Malmon, Magdalena Letowska, Krzysztof Tomasiewicz,
and et al. 2022. "Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product" Viruses 14, no. 6: 1328.
https://doi.org/10.3390/v14061328
APA Style
Lachert, E., Lasocka, J., Bielawski, A., Sulkowska, E., Guz, K., Pyrc, K., Dabrowska, A., Wawryniuk-Malmon, A., Letowska, M., Tomasiewicz, K., & Grabarczyk, P.
(2022). Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product. Viruses, 14(6), 1328.
https://doi.org/10.3390/v14061328
